Omentin-1 in diabetes mellitus: A systematic review and meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Omentin-1 in diabetes mellitus: A systematic review and meta-analysis
Authors
Keywords
Diabetes mellitus, Type 2 diabetes, Enzyme-linked immunoassays, Metaanalysis, Database searching, Gestational diabetes, Insulin, Systematic reviews
Journal
PLoS One
Volume 14, Issue 12, Pages e0226292
Publisher
Public Library of Science (PLoS)
Online
2019-12-11
DOI
10.1371/journal.pone.0226292
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gestational Diabetes and Childhood Obesity
- (2019) Jacob M. Bradshaw et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasma omentin levels are associated with vascular endothelial function in patients with type 2 diabetes at elevated cardiovascular risk
- (2019) Mariko Hayashi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Adipokine levels are associated with insulin resistance in antipsychotics users independently of BMI
- (2019) Trude S. Jahr Vedal et al. PSYCHONEUROENDOCRINOLOGY
- The association between omentin and diabetes: a systematic review and meta-analysis of observational studies
- (2019) Atefeh As´habi et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
- (2018) Philip Ambery et al. LANCET
- Type 1 diabetes
- (2018) Linda A DiMeglio et al. LANCET
- Salivary cortisol in post-traumatic stress disorder: a systematic review and meta-analysis
- (2018) Xiongfeng Pan et al. BMC Psychiatry
- Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors
- (2018) Luca A. Lotta et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial
- (2018) Erin A Bohula et al. LANCET
- Catecholamines in Post-traumatic Stress Disorder: A Systematic Review and Meta-Analysis
- (2018) Xiongfeng Pan et al. Frontiers in Molecular Neuroscience
- Comparative effectiveness of diet alone and diet plus metformin treatment on omentin levels in type 2 diabetes patients with nonalcoholic fatty liver disease: a prospective randomized trial
- (2017) Ibrahim Arslan PERIODICUM BIOLOGORUM
- The Effect of 12 Weeks Aerobic, Resistance, and Combined Exercises on Omentin-1 Levels and Insulin Resistance among Type 2 Diabetic Middle-Aged Women
- (2017) Zeinab AminiLari et al. Diabetes & Metabolism Journal
- Subsequent gestational diabetes mellitus prediction in advanced maternal age using amniotic fluid glucose concentration during second trimester genetic amniocentesis
- (2016) Tharangrut Hanprasertpong et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Meta-analysis in clinical trials revisited
- (2015) Rebecca DerSimonian et al. Contemporary Clinical Trials
- Diabetes
- (2015) David M. Nathan JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adipokines in gestational diabetes
- (2014) Mathias Fasshauer et al. Lancet Diabetes & Endocrinology
- Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation
- (2013) David Castaño et al. JOURNAL OF HEPATOLOGY
- Cardioprotective Properties of Omentin-1 in Type 2 Diabetes: Evidence from Clinical and In Vitro Studies
- (2013) Sabrina Greulich et al. PLoS One
- Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial
- (2013) Alireza Esteghamati et al. REGULATORY PEPTIDES
- Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease
- (2013) Erkan Sengul et al. RENAL FAILURE
- Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes
- (2011) Hye Yoo et al. Cardiovascular Diabetology
- Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus
- (2011) Pijun Yan et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Circulating Omentin as a Novel Biomarker of Endothelial Dysfunction
- (2011) José Maria Moreno-Navarrete et al. Obesity
- Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes
- (2010) Hong-Yan Pan et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Adiponectin Levels and Risk of Type 2 Diabetes
- (2009) Shanshan Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Circulating and Adipose Tissue Gene Expression of Zinc-α2-Glycoprotein in Obesity: Its Relationship with Adipokine and Lipolytic Gene Markers in Subcutaneous and Visceral Fat
- (2009) V. Ceperuelo-Mallafré et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation